Perspectives On The Future Of Pegfilgrastim Biosimilars

Pere Gascón,Ruediger Jankowsky,Karsten Roth

GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL（2017）

引用 0|浏览0

暂无评分

摘要

Cinfa Biotech, the biosimilars specialists of the Cinfa Group, reviewed pegfilgrastim biosimilar approaches to treat chemotherapy-induced neutropenia. Professor Dr Gascon discussed 'perspectives of pegfilgrastim' and Dr Roth and Dr Jankowsky discussed why biosimilars are vital for oncology care.

查看译文

关键词

Biosimilars, biotech, G-CSF, neutropenia, pegfilgrastim

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要